Keywords
Geographic tongue
Pandemic
Stress
SARS-CoV-2
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Report a case of passive geographic tongue that became active due to the presence of severe stress associated to the coronavirus disease 2019 (COVID-19) pandemic. Case details: In January 2019, a 42-years-old Caucasian female was included in a survey on geographic tongue (GT). At that time, although she reported having the condition, on intraoral examination, no atrophic areas or whitish margins were observed on her tongue (classic clinical signs of GT). In November 2020, she was contacted again and reported changes in her GT. At this time, the lateral borders of her tongue presented erythematous areas surrounded by whitish margins. The research participant also reported that she was under severe stress due to the pandemic. Final considerations: This case reported has demonstrated consistency with literature data regarding the onset, worsening of symptoms and changes in clinical aspects of geographic tongue associated with emotional and psychological factors. To ensure that changes in clinical aspects of GT may be related to pandemic stress, further research of oral manifestations of COVID-19 is needed.
References
ALIKHANI M, et al. Immunologic and psychologic parameters associated with geographic tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 118: 68-71.
ANSARI M, et al. Dynamic assessment of economic and environmental performance index and generation, composition, environmental and human health risks of hospital solid waste in developing countries; A state of the art of review. Environment International, 2019; 132: 105073.
BERNAOLA PAREDES WE, et al. A case of migratory stomatitis in a young male patient: Management and differential diagnosis. J Oral Maxillofac Pathol., 2022; 26: S17-21.
CAMPANA F, et al. Geographic stomatitis with palate involvement. An Bras Dermatol. 2019; 94(4): 449-51.
CAMPBELL CM, KAHWASH R. Will complement inhibition be the new target in treating COVID-19–related systemic thrombosis? Circulation. 2020; 141(22): 1739–41.
CAMPOS WG, et al. Treatment of symptomatic benign migratory glossitis: a systematic review. Clin Oral Investig. 2018; 22(7): 2487-2493.
CARRERAS-PRESAS CM, et al. Oral vesiculobullous lesions associated with Sars-Cov-2 infection. Oral Diseases. 2020; 00: 1–3.
CHEN N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13.
CHEVANCE A, et al. Ensuring mental health care during the Sars-Cov-2 epidemic in France: A narrative review. L’Encéphale. 2020; 46: 193–201.
DU Y, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Critic Care Med. 2020; 201(11): 1372–9.
ESTÉBANEZ A, et al. Cutaneous manifestations in COVID‐19: a new contribution. Journal of the European Academy of Dermatology and Venereology. 2020; 34(6): e250-e251.
GONZAGA HF, et al. Environmental factors in benign migratory glossitis and psoriasis: retrospective study of the association of emotional stress and alcohol and tobacco consumption with benign migratory glossitis and cutaneous psoriasis. J Eur Acad, Dermatol.Venereol. 2015; 29: 533-6.
GONZÁLEZ-ÁLVAREZ L, et al. Lengua geográfica: factores predisponentes, diagnóstico y tratamiento. Revisión sistemática. Rev Clin Esp. 2018; 218(9): 481-488.
GOSWAMI M, et al. Benign migratory glossitis with fissured tongue. J Indian Soc Pedod Prev Dent. 2012; 30(2): 173-175
GUO YR, et al. The origin, transmission, and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research. 2020; 7(1): 1-10.
JERNIGAN DB. Update: Public health response to the coronavirus disease 2019 outbreak. — United States, February 24, 2020. Morb Mortal Wkly Report. 2020; 69(8): 216-219.
KAUR D, et al. Oral manifestations of stress-related disorders in the general population of Ludhiana. J Indian Acad Oral Med Radiol. 2016; 28: 262-269.
LUI DTW, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021; 106: e926–e935.
MAGLIOCCA KR, FITZPATRICK SG. Autoimmune disease manifestations in the oral cavity. Surg Pathol Clin. 2017; 10: 57-88.
MALLAH SI, et al. COVID‑19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 2021;20(35):1-36.
MANGOLD AR, et al. Diseases of the tongue. Clin Dermatol. 2016; 34: 458-69.8
OGUETA IC, et al. Geographic Tongue: What a Dermatologist Should Know. Actas Dermosifiliogr. 2019; 110(5): 341-346.
PICCIANI BLS, et al. Geographic tongue severity index: A new and clinical scoring system. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020; 129(4): 330‐338.
PINNA R, et al. Genetic and developmental disorders of the oral mucosa: Epidemiology; molecular mechanisms; diagnostic criteria; management. Periodontol 2000. 2019; 80: 12–27.
PRASANTH VJ. Geographic Tongue. CMAJ. 2021; 13(193): E1424.
PREM K, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020; 5(5): e261-e270
QIU J, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: Implications and policy recommendations. Gen. Psychiatry. 2020; 33: e100213.
SANTOS JA, et al. Oral mucosal lesions in a COVID‐19 patient: new signs or secondary manifestations? Int J Infect Dis. 2020; 97: 326‐ 328.
SCALA A, et al. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275 91.
SCARIOT R, et al. Host and clinical aspects in patients with benign migratory glossitis. Arch OralBiol. 2017; 73: 259-68.
SEAH I, AGRAWAL R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28(3): 391–5.
TANG N, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–7.
TOSCANO G, et al. Guillain- Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382: 2574–2576.
TO K K-W, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerging Microbes & Infections. 2021; 10: 507-535.
VINDEGAARD N, BENROS ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020, 89: 531–542.
XU H, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int JOral Sci. 2020; 12(1): 8.
XU L, et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40(5): 998–1004.
WORLD HEALTH ORGANIZATION (WHO). WHO announces COVID-19 outbreak a pandemic. Geneva: World Health Organization; 2020.